Lenomorelin (Ghrelin) is a pleiotropic hormone, whose effect on growth hormone secretion, through the growth hormone secretagogue (GHS) receptor, is one of its many actions. It is synthesized principally in the stomach. Ghrelin-producing cells constitute a distinct group of endocrine cells dispersed throughout the gastric mucosa and to a lesser extent in the small intestine and the endocrine pancreas. Ghrelin plasma levels rise during fasting and chronic caloric restriction to stimulate food intake and fat storage and to prevent life-threatening falls in blood glucose. Plasma ghrelin levels decrease after a meal is consumed and in conditions of energy surplus (such as obesity). Ghrelin has emerged as a key player in the regulation of appetite and energy homeostasis. It stimulates food intake and transduces signals to hypothalamic regulatory nuclei that control energy homeostasis. Ghrelin levels are negatively correlated with body mass index (BMI) and insulin resistance. Lenomorelin is a peptide of 28 amino acids, in which the serine 3 residue is n-octanoylated, which is necessary for biological activity.
Approval Year
Substance Class |
Protein
Created
by
admin
on
Edited
Sat Dec 16 11:22:28 GMT 2023
by
admin
on
Sat Dec 16 11:22:28 GMT 2023
|
Protein Type | HORMONE |
Protein Sub Type | |
Sequence Origin | HUMAN |
Sequence Type | COMPLETE |
Record UNII |
UXG268Q86R
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
LOINC |
76474-6
Created by
admin on Sat Dec 16 11:22:28 GMT 2023 , Edited by admin on Sat Dec 16 11:22:28 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHEMBL2108303
Created by
admin on Sat Dec 16 11:22:28 GMT 2023 , Edited by admin on Sat Dec 16 11:22:28 GMT 2023
|
PRIMARY | |||
|
258279-04-8
Created by
admin on Sat Dec 16 11:22:28 GMT 2023 , Edited by admin on Sat Dec 16 11:22:28 GMT 2023
|
PRIMARY | |||
|
m5723
Created by
admin on Sat Dec 16 11:22:28 GMT 2023 , Edited by admin on Sat Dec 16 11:22:28 GMT 2023
|
PRIMARY | Merck Index | ||
|
DB11895
Created by
admin on Sat Dec 16 11:22:28 GMT 2023 , Edited by admin on Sat Dec 16 11:22:28 GMT 2023
|
PRIMARY | |||
|
9341
Created by
admin on Sat Dec 16 11:22:28 GMT 2023 , Edited by admin on Sat Dec 16 11:22:28 GMT 2023
|
PRIMARY | |||
|
D054439
Created by
admin on Sat Dec 16 11:22:28 GMT 2023 , Edited by admin on Sat Dec 16 11:22:28 GMT 2023
|
PRIMARY | |||
|
UXG268Q86R
Created by
admin on Sat Dec 16 11:22:28 GMT 2023 , Edited by admin on Sat Dec 16 11:22:28 GMT 2023
|
PRIMARY | |||
|
75431
Created by
admin on Sat Dec 16 11:22:28 GMT 2023 , Edited by admin on Sat Dec 16 11:22:28 GMT 2023
|
PRIMARY | |||
|
C170105
Created by
admin on Sat Dec 16 11:22:28 GMT 2023 , Edited by admin on Sat Dec 16 11:22:28 GMT 2023
|
PRIMARY | |||
|
91668172
Created by
admin on Sat Dec 16 11:22:28 GMT 2023 , Edited by admin on Sat Dec 16 11:22:28 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> AGONIST |
EC50
|
||
|
SALT/SOLVATE -> PARENT | |||
|
INGREDIENT -> STARTING MATERIAL |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE ACTIVE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
MOL_WEIGHT:SEQUENCE(CALCULATED) | CHEMICAL |
|
||||
Molecular Formula | CHEMICAL |
|